Folli Stefano
Transaction: 08/01/2026
OTHER
Change
+6,273
Price
Not reported
Filing
08/05/2026
Type
OTHER
LivaNova PLC
LIVN • Medical - Devices
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$4.16B
Growth
26.8%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 5.6%Positive free cash flow · 3.18Consistent free cash flow · 5/5Manageable debt level · 0.39Healthy liquidity · 1.36
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:46 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$4.16B
52W Range47.13 - 85.76
Beta0.86
Gross Margin67.71%
Oper. Margin14.36%
Profit Margin-17.47%
Debt/Eq0.39
Current Ratio1.36
Quick Ratio1.16
Revenue 5Y26.81%
Price$0.00
Change0.00%
Market Cap$4.16B
52W Range47.13 - 85.76
Beta0.86
Gross Margin67.71%
Oper. Margin14.36%
Profit Margin-17.47%
Debt/Eq0.39
Current Ratio1.36
Quick Ratio1.16
Revenue 5Y26.81%
Target$87.67
Target Median$88.50
Target Range76.00 - 95.00
Volume817.84K
Avg Volume754.24K
EPS Surprise0.13
Investment DNA
How strong this company looks for long-term investors
69
out of 100
Business Quality
Margins, moat, returns
37/100
Financial Strength
Debt, cash, stability
71/100
Growth Potential
Revenue and expansion
84/100
Price Attractiveness
Cheap or expensive today
79/100
Why this score▼
Positive revenue growth · 5.6%Positive free cash flow · 3.18Consistent free cash flow · 5/5Manageable debt level · 0.39Healthy liquidity · 1.36Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$76.00
Mean
$87.67
Median
$88.50
High
$95.00
Insider Transactions
Recent executive and insider activity
Zurbay Donald
Transaction: 06/15/2026
SELL
Change
-2,560
Price
Not reported
Filing
06/17/2026
Type
SELL
Zurbay Donald
Transaction: 06/15/2026
SELL
Change
-308
Price
$79.70
Filing
06/17/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Folli Stefano | OTHER | +6,273 | Not reported | 08/01/2026 | 08/05/2026 |
| Zurbay Donald | SELL | -2,560 | Not reported | 06/15/2026 | 06/17/2026 |
| Zurbay Donald | SELL | -308 | $79.70 | 06/15/2026 | 06/17/2026 |
| Story Brooke | SELL | -4,042 | Not reported | 06/15/2026 | 06/17/2026 |
| Story Brooke | SELL | -486 | $79.70 | 06/15/2026 | 06/17/2026 |
| Enxing Seng Stacy | SELL | -4,042 | Not reported | 06/15/2026 | 06/17/2026 |
| Enxing Seng Stacy | SELL | -486 | $79.70 | 06/15/2026 | 06/17/2026 |
| KOZY WILLIAM A | SELL | -5,681 | Not reported | 06/15/2026 | 06/17/2026 |
| KOZY WILLIAM A | SELL | -682 | $79.70 | 06/15/2026 | 06/17/2026 |
| Nygaard-Andersen Jette | BUY | +2,383 | Not reported | 06/15/2026 | 06/17/2026 |
| Tezel Ahmet | SELL | -2,965 | Not reported | 06/15/2026 | 06/17/2026 |
| Tezel Ahmet | SELL | -1,032 | $79.70 | 06/15/2026 | 06/17/2026 |
| Barry James Christopher | SELL | -4,042 | Not reported | 06/15/2026 | 06/17/2026 |
| Barry James Christopher | SELL | -486 | $79.70 | 06/15/2026 | 06/17/2026 |
| PODLOGAR SUSAN M | SELL | -4,042 | Not reported | 06/15/2026 | 06/17/2026 |
| PODLOGAR SUSAN M | SELL | -486 | $79.70 | 06/15/2026 | 06/17/2026 |
| Bianchi Francesco | SELL | -4,042 | Not reported | 06/15/2026 | 06/17/2026 |
| Bianchi Francesco | SELL | -1,200 | $80.19 | 06/15/2026 | 06/17/2026 |
| SCHERMERHORN TODD C | SELL | -4,042 | Not reported | 06/15/2026 | 06/17/2026 |
| SCHERMERHORN TODD C | SELL | -486 | $79.70 | 06/15/2026 | 06/17/2026 |